Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 8.52 Billion | USD 17.08 Billion | 7.2% | 2024 |
The global enteral nutrition market size was worth around USD 8.52 Billion in 2024 and is predicted to grow to around USD 17.08 Billion by 2034 with a compound annual growth rate (CAGR) of roughly 7.2% between 2025 and 2034. The report analyzes the global enteral nutrition market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the enteral nutrition industry.
Enteral nutrition refers to any method of eating that involves the passage of food through the digestive tract to meet an individual's caloric needs. In addition, this may also include a regular diet, the use of liquid or powdered supplements, and tube feeding. There are many different devices and devices available to patients for enteral nutrition. These include tubes, pumps, and other flexible tubes that help facilitate fluid flow directly into the digestive tract. Enteral nutrition is essential for people with diabetes, malnutrition, cancer, digestive disorders, and other complications. Alternatively, enteral nutrition may be provided to patients with nutritional deficiencies. An increase in chronic diseases, such as cancer, stroke, multiple sclerosis, dementia, chronic liver disease, chronic obstructive pulmonary disease (COPD), and diabetes is expected to drive demand for products that help patients with oral absorption problems.
Furthermore, the increase in preterm births is one of the crucial factors driving the demand for enteral formula milk to meet the nutritional needs of infants. In addition, the lack of understanding and awareness of clinical nutrition in the medical and healthcare communities has limited its adoption and development. Technological advancement and product innovation are other factors driving the global enteral nutrition market growth.
The rising investment in R&D aids the global market growth
Factors such as investment in research and development of new medical nutrition products targeting different health conditions and funding by other companies operating in the nutrition industry are expected to drive the growth of the global enteral nutrition market throughout the forecast period. For example, in May 2020, Danone's health nutrition arm, Nutricia, awarded USD 1.1 million to the Global Nutrition Research Program, a research project led by clinicians initiated in 16 countries around the world to define nutritional care guidelines for COVID-19 patients recovering from intensive care (ICU) admission.
The lack of understanding may hamper the global market growth
The lack of understanding and awareness of clinical nutrition in the medical and healthcare communities has limited the adoption and development of enteral nutrition. In addition, clinical nutrition requires higher prescription and supervision by medical professionals, which further limits the market's growth. In addition, although these products are gaining more and more acceptance, they are still not fully understood by doctors, patients, and pharmacists. This is one of the major factors restricting physicians from prescribing, recommending, or adopting clinical nutrition, thus holding back the market's growth.
The promising product portfolio brings up several growth opportunities
Technological advancement and product innovation are some of the other factors driving the enteral nutrition market growth. The diversified product portfolio and strong product development offered by the leading players in the market positively impact the growth of the market. Ready-to-use (RTD) and ready-to-use nutritional supplements, tube feeding, and tube feeding for specific indications are some product categories that have gained traction in recent years.
For example, PulmoCare, offered by Abbott, is a dietary supplement for people with COPD. In addition, introducing more and more new products is a significant factor positively influencing the growth of the tube feeding sector. For instance, in 2020, Victus, Inc. announced the launch of ABINTRA Care, specialized nutrition that can support the immune system. This will help the company grow its product portfolio in the specialty nutrition segment.
The global enteral nutrition market is segregated based on protein composition, form, age group, distribution channel, and region.
By protein composition, the market is bifurcated into high protein supplements, standard protein diets, protein for diabetes care patients, and others. Among these, standard protein diets dominate the global enteral nutrition market in 2021 and are expected to continue this trend during the forecast period. Key factors include adopting a wide variety of standard protein diets as it is one of the most appropriate preparations prescribed for patients with diabetes, cancer, and other medical conditions in which they find it difficult to eat solid food. The launch of various protein-rich standard products to meet market demand.
The distribution channel bifurcates the market into hospital sales, retail, and online. The hospital sales segment accounted for the maximum revenue in the market in 2021 and is expected to dominate in the coming years. This is due to the hospital's more significant number of inpatients and outpatients. The hospital sales segment is also expected to grow due to increased patient preference for hospitals.
Based on Product Type, the global enteral nutrition market is divided into Standard Formula, Disease-Specific Formula.
On the basis of Form, the global enteral nutrition market is bifurcated into Liquid, Powder.
By Flow Type, the global enteral nutrition market is split into Continuous Feeding, Intermittent Feeding.
In terms of Age Group, the global enteral nutrition market is categorized into Pediatric, Adults, Geriatric.
Report Attributes | Report Details |
---|---|
Report Name | Global Enteral Nutrition Market |
Market Size in 2024 | USD 8.52 Billion |
Market Forecast in 2034 | USD 17.08 Billion |
Growth Rate | CAGR of 7.2% |
Number of Pages | 277 |
Key Companies Covered | B. BRAUN MELSUNGEN AG, ABBOTT LABORATORIES, FRESENIUS KABI AG, DANONE S.A., HORMEL FOODS CORPORATION, GLOBAL HEALTH PRODUCTS, INC., MEIJI HOLDINGS CO., LTD., RECKITT BENCKISER GROUP PLC., NESTLE S.A, and VICTUS, INC., and others. |
Segments Covered | By Product Type, By Form, By Flow Type, By Age Group, By End-user, By Distribution Channel, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, The Middle East and Africa (MEA) |
Base Year | 2024 |
Historical Year | 2020 to 2024 |
Forecast Year | 2025 to 2034 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The increasing prevalence of BPH helps North America dominate the global market
North America dominated the global enteral nutrition market and accounts for the largest revenue share of 32% in 2021 due to the growing burden of chronic diseases such as diabetes, cancer, and other neurological diseases. In addition, the growing preference for at-home enteral therapy has reduced the number of patients visiting hospitals and clinics. In addition, increasing malnutrition is expected to drive further demand for enteral nutrition in this region.
Additionally, in the Asia Pacific, the market is expected to show attractive growth over the forecast period. The increasing rate of preterm births is one of the key factors driving demand in the region. According to the World Health Organization (WHO), India, China, Nigeria, Pakistan, and Indonesia are among the five countries with the highest number of premature births. Factors such as increased spending on healthcare and recent improvement of healthcare infrastructure in many countries, including China, Japan, India, and Singapore, are expected to drive the market in the coming years.
The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the enteral nutrition market on a global and regional basis.
The global enteral nutrition market is dominated by players like:
By Product Type
By Form
By Flow Type
By Age Group
By End-user
By Distribution Channel
By Region
FrequentlyAsked Questions
The global enteral nutrition market is expected to grow due to increasing prevalence of chronic diseases, aging population, and preference for home healthcare and nutritional support.
According to a study, the global enteral nutrition market size was worth around USD 8.52 Billion in 2024 and is expected to reach USD 17.08 Billion by 2034.
The global enteral nutrition market is expected to grow at a CAGR of 7.2% during the forecast period.
North America is expected to dominate the enteral nutrition market over the forecast period.
Leading players in the global enteral nutrition market include B. BRAUN MELSUNGEN AG, ABBOTT LABORATORIES, FRESENIUS KABI AG, DANONE S.A., HORMEL FOODS CORPORATION, GLOBAL HEALTH PRODUCTS, INC., MEIJI HOLDINGS CO., LTD., RECKITT BENCKISER GROUP PLC., NESTLE S.A, and VICTUS, INC., among others.
The report explores crucial aspects of the enteral nutrition market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed